VR-AD-1005
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for VR-AD-1005, covering 2026-03-12 to 2026-03-12. Get the full timeline:
Most recent: Clinical Trial Update: Assessment of a Novel Fixed-dose Combination (FDC) Drug VR-AD-1005 for the Treatment of Acute Watery Diarrhea in Cholera [Phase 2]